| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/11/2011 | CN102056923A New co-crystal compound of rivaroxaban and malonic acid |
| 05/11/2011 | CN102056922A Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIA |
| 05/11/2011 | CN102056921A Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
| 05/11/2011 | CN102056919A Substituted sulfonamide derivatives |
| 05/11/2011 | CN102056918A Pyrrolidine ether derivatives as NK3 receptor antagonists |
| 05/11/2011 | CN102056917A Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 05/11/2011 | CN102056910A Styrylbenzofuran derivatives as inhibitors for beta-amyloid fibril formation and preparation method thereof |
| 05/11/2011 | CN102056908A New terpenes and macrocycles |
| 05/11/2011 | CN102056907A Heterocyclic derivative and use thereof |
| 05/11/2011 | CN102056905A Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof |
| 05/11/2011 | CN102056904A Indane derivatives as AMPA receptor modulators |
| 05/11/2011 | CN102056903A New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases |
| 05/11/2011 | CN102056902A Imidazolidine derivatives |
| 05/11/2011 | CN102056900A Compounds and compositions as modulators of GPR119 activity |
| 05/11/2011 | CN102056898A Amide derivatives as positive allosteric modulators and methods of use thereof |
| 05/11/2011 | CN102056897A Sulfonamide compound and application thereof |
| 05/11/2011 | CN102056894A Homocysteine synthase inhibitor |
| 05/11/2011 | CN102056887A Process for the preparation of prostaglandin analogues and intermediates thereof |
| 05/11/2011 | CN102056630A Stabilizer for lymph vessel |
| 05/11/2011 | CN102056629A A photosensitising composition and its uses |
| 05/11/2011 | CN102056614A Compositions for the treatment of disorders of the upper respiratory tract and influenza syndroms |
| 05/11/2011 | CN102056613A Method for preventing corticosteroid usage |
| 05/11/2011 | CN102056611A Method and pharmaceutical composition for obtaining the plasmatic progesterone levels required for different therapeutic indications |
| 05/11/2011 | CN102056610A Fine granules having improved suspension performance in water |
| 05/11/2011 | CN102056609A Pharmaceutical combination |
| 05/11/2011 | CN102056608A SOFINICLINE (ABT-894 ) for attention-deficit/hyperactivity disorder |
| 05/11/2011 | CN102056607A ON01910. NA enhances chemotherapeutic agent activity in drug-resistant tumors |
| 05/11/2011 | CN102056606A Dpp-iv inhibitors for use in the treatment of nafld |
| 05/11/2011 | CN102056605A Pharmaceutical composition |
| 05/11/2011 | CN102056604A Composition for the treatment of arthritis containing a dibenzo-p-dioxin derivative as the active ingredient |
| 05/11/2011 | CN102056603A Dronedarone for the prevention of permanent atrial fibrillation |
| 05/11/2011 | CN102056602A Dronedarone for the prevention of cardioversion |
| 05/11/2011 | CN102056601A Method for inhibiting the growth of bacteria |
| 05/11/2011 | CN102056600A Combination therapy for the treatment of bacterial infections |
| 05/11/2011 | CN102056599A Pharmaceutical dosage form for immediate release of an indolinone derivative |
| 05/11/2011 | CN102056598A Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative |
| 05/11/2011 | CN102056596A Nanoparticle formulations and uses thereof |
| 05/11/2011 | CN102056594A Pharmaceutical depot comprising N-{5-[(cyclopropylamino)carbonyl]-2-methylphenyl}-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide |
| 05/11/2011 | CN102056590A Pharmaceutical compositions containing a fluoroquinolone antibiotic drug |
| 05/11/2011 | CN102056589A Solid pharmaceutical formulations comprising BIBW 2992 |
| 05/11/2011 | CN102056499A Composition for regulating lipid metabolism |
| 05/11/2011 | CN102056490A Highly active antioxidant based on trehalulose |
| 05/11/2011 | CN102056485A Topical LFA-1 antagonists for use in localized treatment of immune related disorders |
| 05/11/2011 | CN102056484A Steroid treatment for hot flashes |
| 05/11/2011 | CN102056483A Small molecule inhibitors for the treatment or prevention of dengue virus infection |
| 05/11/2011 | CN102056481A Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent |
| 05/11/2011 | CN102051394A Preparation method and application of sulfo-diketopiperazine compounds |
| 05/11/2011 | CN102051392A Chlorhematin and preparation method thereof as well as blood-enriching pharmaceutical composition |
| 05/11/2011 | CN102050864A Transplanted wild ginseng ginsenoside B as well as extraction method and medical application thereof |
| 05/11/2011 | CN102050862A New honeysuckle chlorogenic acid ester saponin as well as preparation method and use thereof |
| 05/11/2011 | CN102050860A Preparation method of 24(R)-ocotillol DQ and pharmacal application thereof |
| 05/11/2011 | CN102050856A High-activity epirubicin derivative, preparation method thereof and application thereof |
| 05/11/2011 | CN102050852A 2'-O-rhamnosyl swertisin, preparation of analogues thereof, and application thereof |
| 05/11/2011 | CN102050849A Forsythoside A and preparation method thereof |
| 05/11/2011 | CN102050847A Extraction and separation method of tannic acid used for curing spontaneous perspiration and night sweat, tannic acid preparation and preparation method of tannic acid preparation |
| 05/11/2011 | CN102050846A Amino sugar, and preparation method and use thereof |
| 05/11/2011 | CN102050838A Sulfoxide isothiocyanicacid alkane metal complexing compound and application thereof |
| 05/11/2011 | CN102050832A Melonines bisindole compound, medicine composition, preparation method and application thereof |
| 05/11/2011 | CN102050831A Cephalosporin derivative |
| 05/11/2011 | CN102050830A Cephalosporin derivative containing nitrogen-containing fused-heterocycle |
| 05/11/2011 | CN102050828A Prasugrel salt and preparation method thereof |
| 05/11/2011 | CN102050824A Piperazinoltriazole derivatives |
| 05/11/2011 | CN102050821A Novel imidazo(1,5-a)pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/11/2011 | CN102050819A Oxazolidone derivative as well as preparation method and purposes thereof |
| 05/11/2011 | CN102050818A Puerarin derivatives containing nitrate substituent groups and preparation method and medicinal application thereof |
| 05/11/2011 | CN102050815A Dabigatran ester derivatives as prodrug |
| 05/11/2011 | CN102050814A Ester derivatives of dabigatran |
| 05/11/2011 | CN102050812A 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| 05/11/2011 | CN102050811A 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| 05/11/2011 | CN102050810A Medicine for treating rheumatoid arthritis and preparation method thereof |
| 05/11/2011 | CN102050809A Chemokine-like factor 1 (CKLF1)/C chemokine receptor 4 (CCR4) interaction-antagonistic 3-peperazinyl coumarin derivatives |
| 05/11/2011 | CN102050807A 3-aryl-4-(2-acyloxy ethyoxyl)-2(5H)-furanone compound and preparation method and application thereof |
| 05/11/2011 | CN102050802A N-(2-ethoxyl)ferulamide nitrate derivative with anoxia resisting pharmaceutical activity and preparation method thereof |
| 05/11/2011 | CN102050801A Method for preparing arylpiperazines derivative optical isomer |
| 05/11/2011 | CN102050793A 4(3H) quinazolinone derivatives with antitumor activity |
| 05/11/2011 | CN102050792A 2-[(substituted phenylamino) carboxyl methylmercapto]-6-aryl-3H-pyrimidine-4-ketone derivative as well as preparation method and application thereof |
| 05/11/2011 | CN102050787A Guanidine derivatives and preparation, medicinal composition and application in preparation of medicaments for treating metabolic syndromes |
| 05/11/2011 | CN102050780A Quinoline derivatives, and medicament composition and application thereof |
| 05/11/2011 | CN102050772A Bimatoprost crystal as well as preparation method and purposes thereof |
| 05/11/2011 | CN102050770A Sulfoxide-based alkane isothiocyanate optical isomer and application thereof in preparation of drugs |
| 05/11/2011 | CN102050759A Resveratrol amide derivative and preparation method thereof |
| 05/11/2011 | CN102050758A Novel amide derivatives and medicinal use thereof |
| 05/11/2011 | CN102050755A Novel agomelatine crystal forms and preparation methods of agomelatine crystal forms |
| 05/11/2011 | CN102050733A Biphenyl cyclooctene type lignan compound and medicinal application thereof |
| 05/11/2011 | CN102050720A Novel DHA derivative and its usage as medicine |
| 05/11/2011 | CN102050717A Dysideavillosa element A, element B and element C as well as preparation method and application thereof in preparation of drugs |
| 05/11/2011 | CN102050703A Resveratrol derivate as well as preparation method and application thereof |
| 05/11/2011 | CN102049091A Special medicine bag for treating pain in waist and lower extremities by applying hot compress |
| 05/11/2011 | CN102049089A Seat cushion for treating haemorrhoids |
| 05/11/2011 | CN102049051A Medicinal composition for stabilizing pholcodine granules |
| 05/11/2011 | CN102049049A Medical composition containing aspirin salt and stanin medicaments |
| 05/11/2011 | CN102049048A Method of treatment or prophylaxis |
| 05/11/2011 | CN102049047A Drug combination |
| 05/11/2011 | CN102049044A Calcium supplementing composition preparation for improving calcium absorption |
| 05/11/2011 | CN102049035A Starch polysaccharide-iron compound preparation |
| 05/11/2011 | CN102049033A Medicament for intervention treatment of chronic obstructive pulmonary disease and preparation method thereof |
| 05/11/2011 | CN102049027A Traditional Chinese medicine preparation for treating chronic gastritis |
| 05/11/2011 | CN102049023A Traditional Chinese medicine formula for treating vaginal discharge diseases |
| 05/11/2011 | CN102049018A Preparation method of ointment for treating sprain |
| 05/11/2011 | CN102049016A Externally applied medicine for treating rheumatoid arthritis |